This report aims to provide a comprehensive presentation of the global market for RNA Interference (RNAi) Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Interference (RNAi) Drug Delivery. This report contains market size and forecasts of RNA Interference (RNAi) Drug Delivery in global, including the following market information:
Global RNA Interference (RNAi) Drug Delivery Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global RNA Interference (RNAi) Drug Delivery Market Sales, 2019-2024, 2024-2029, (K Units)
Global top five RNA Interference (RNAi) Drug Delivery companies in 2023 (%)
The global RNA Interference (RNAi) Drug Delivery market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Nanoparticle Drug Delivery Technology Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNA Interference (RNAi) Drug Delivery include Metabolic disorders, Alnylam Pharmaceuticals Inc, Merck & Co. Inc, Access Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, Calondo Pharmaceuticals Inc, Marina Biotech Inc, RXi Pharmaceuticals Corp and Quark Pharmaceuticals Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNA Interference (RNAi) Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA Interference (RNAi) Drug Delivery Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global RNA Interference (RNAi) Drug Delivery Market Segment Percentages, by Type, 2023 (%)
Nanoparticle Drug Delivery Technology
Pulmonary Drug Delivery Technology
Nucleic Acid Drug Delivery Technology
Aptamer Drug Delivery Technology
Global RNA Interference (RNAi) Drug Delivery Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global RNA Interference (RNAi) Drug Delivery Market Segment Percentages, by Application, 2023 (%)
Infectious Diseases
Cardiology
Oncology
Neurology
Ophthalmology
Metabolic Disorders
Global RNA Interference (RNAi) Drug Delivery Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global RNA Interference (RNAi) Drug Delivery Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA Interference (RNAi) Drug Delivery revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies RNA Interference (RNAi) Drug Delivery revenues share in global market, 2023 (%)
Key companies RNA Interference (RNAi) Drug Delivery sales in global market, 2019-2024 (Estimated), (K Units)
Key companies RNA Interference (RNAi) Drug Delivery sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Metabolic disorders
Alnylam Pharmaceuticals Inc
Merck & Co. Inc
Access Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Calondo Pharmaceuticals Inc
Marina Biotech Inc
RXi Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Silence Therapeutics plc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc
Traversa Therapeutics Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA Interference (RNAi) Drug Delivery, market overview.
Chapter 2: Global RNA Interference (RNAi) Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of RNA Interference (RNAi) Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA Interference (RNAi) Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global RNA Interference (RNAi) Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA Interference (RNAi) Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA Interference (RNAi) Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Interference (RNAi) Drug Delivery Overall Market Size
2.1 Global RNA Interference (RNAi) Drug Delivery Market Size: 2022 VS 2031
2.2 Global RNA Interference (RNAi) Drug Delivery Revenue, Prospects & Forecasts: 2019-2031
2.3 Global RNA Interference (RNAi) Drug Delivery Sales: 2019-2031
3 Company Landscape
3.1 Top RNA Interference (RNAi) Drug Delivery Players in Global Market
3.2 Top Global RNA Interference (RNAi) Drug Delivery Companies Ranked by Revenue
3.3 Global RNA Interference (RNAi) Drug Delivery Revenue by Companies
3.4 Global RNA Interference (RNAi) Drug Delivery Sales by Companies
3.5 Global RNA Interference (RNAi) Drug Delivery Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 RNA Interference (RNAi) Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA Interference (RNAi) Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 RNA Interference (RNAi) Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 RNA Interference (RNAi) Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA Interference (RNAi) Drug Delivery Market Size Markets, 2022 & 2031
4.1.2 Nanoparticle Drug Delivery Technology
4.1.3 Pulmonary Drug Delivery Technology
4.1.4 Nucleic Acid Drug Delivery Technology
4.1.5 Aptamer Drug Delivery Technology
4.2 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue, 2019-2024
4.2.2 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue, 2024-2031
4.2.3 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
4.3 By Type - Global RNA Interference (RNAi) Drug Delivery Sales & Forecasts
4.3.1 By Type - Global RNA Interference (RNAi) Drug Delivery Sales, 2019-2024
4.3.2 By Type - Global RNA Interference (RNAi) Drug Delivery Sales, 2024-2031
4.3.3 By Type - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
4.4 By Type - Global RNA Interference (RNAi) Drug Delivery Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA Interference (RNAi) Drug Delivery Market Size, 2022 & 2031
5.1.2 Infectious Diseases
5.1.3 Cardiology
5.1.4 Oncology
5.1.5 Neurology
5.1.6 Ophthalmology
5.1.7 Metabolic Disorders
5.2 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue, 2019-2024
5.2.2 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue, 2024-2031
5.2.3 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
5.3 By Application - Global RNA Interference (RNAi) Drug Delivery Sales & Forecasts
5.3.1 By Application - Global RNA Interference (RNAi) Drug Delivery Sales, 2019-2024
5.3.2 By Application - Global RNA Interference (RNAi) Drug Delivery Sales, 2024-2031
5.3.3 By Application - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
5.4 By Application - Global RNA Interference (RNAi) Drug Delivery Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global RNA Interference (RNAi) Drug Delivery Market Size, 2022 & 2031
6.2 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue, 2019-2024
6.2.2 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue, 2024-2031
6.2.3 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
6.3 By Region - Global RNA Interference (RNAi) Drug Delivery Sales & Forecasts
6.3.1 By Region - Global RNA Interference (RNAi) Drug Delivery Sales, 2019-2024
6.3.2 By Region - Global RNA Interference (RNAi) Drug Delivery Sales, 2024-2031
6.3.3 By Region - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America RNA Interference (RNAi) Drug Delivery Revenue, 2019-2031
6.4.2 By Country - North America RNA Interference (RNAi) Drug Delivery Sales, 2019-2031
6.4.3 US RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.4.4 Canada RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.4.5 Mexico RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue, 2019-2031
6.5.2 By Country - Europe RNA Interference (RNAi) Drug Delivery Sales, 2019-2031
6.5.3 Germany RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.5.4 France RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.5.5 U.K. RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.5.6 Italy RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.5.7 Russia RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.5.8 Nordic Countries RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.5.9 Benelux RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue, 2019-2031
6.6.2 By Region - Asia RNA Interference (RNAi) Drug Delivery Sales, 2019-2031
6.6.3 China RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.6.4 Japan RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.6.5 South Korea RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.6.6 Southeast Asia RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.6.7 India RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America RNA Interference (RNAi) Drug Delivery Revenue, 2019-2031
6.7.2 By Country - South America RNA Interference (RNAi) Drug Delivery Sales, 2019-2031
6.7.3 Brazil RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.7.4 Argentina RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales, 2019-2031
6.8.3 Turkey RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.8.4 Israel RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.8.5 Saudi Arabia RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
6.8.6 UAE RNA Interference (RNAi) Drug Delivery Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Metabolic disorders
7.1.1 Metabolic disorders Company Summary
7.1.2 Metabolic disorders Business Overview
7.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.1.4 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.1.5 Metabolic disorders Key News & Latest Developments
7.2 Alnylam Pharmaceuticals Inc
7.2.1 Alnylam Pharmaceuticals Inc Company Summary
7.2.2 Alnylam Pharmaceuticals Inc Business Overview
7.2.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.2.5 Alnylam Pharmaceuticals Inc Key News & Latest Developments
7.3 Merck & Co. Inc
7.3.1 Merck & Co. Inc Company Summary
7.3.2 Merck & Co. Inc Business Overview
7.3.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.3.4 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.3.5 Merck & Co. Inc Key News & Latest Developments
7.4 Access Pharmaceuticals Inc
7.4.1 Access Pharmaceuticals Inc Company Summary
7.4.2 Access Pharmaceuticals Inc Business Overview
7.4.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.4.4 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.4.5 Access Pharmaceuticals Inc Key News & Latest Developments
7.5 Dicerna Pharmaceuticals Inc
7.5.1 Dicerna Pharmaceuticals Inc Company Summary
7.5.2 Dicerna Pharmaceuticals Inc Business Overview
7.5.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.5.4 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.5.5 Dicerna Pharmaceuticals Inc Key News & Latest Developments
7.6 Calondo Pharmaceuticals Inc
7.6.1 Calondo Pharmaceuticals Inc Company Summary
7.6.2 Calondo Pharmaceuticals Inc Business Overview
7.6.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.6.4 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.6.5 Calondo Pharmaceuticals Inc Key News & Latest Developments
7.7 Marina Biotech Inc
7.7.1 Marina Biotech Inc Company Summary
7.7.2 Marina Biotech Inc Business Overview
7.7.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.7.4 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.7.5 Marina Biotech Inc Key News & Latest Developments
7.8 RXi Pharmaceuticals Corp
7.8.1 RXi Pharmaceuticals Corp Company Summary
7.8.2 RXi Pharmaceuticals Corp Business Overview
7.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.8.4 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.8.5 RXi Pharmaceuticals Corp Key News & Latest Developments
7.9 Quark Pharmaceuticals Inc
7.9.1 Quark Pharmaceuticals Inc Company Summary
7.9.2 Quark Pharmaceuticals Inc Business Overview
7.9.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.9.4 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.9.5 Quark Pharmaceuticals Inc Key News & Latest Developments
7.10 Silence Therapeutics plc
7.10.1 Silence Therapeutics plc Company Summary
7.10.2 Silence Therapeutics plc Business Overview
7.10.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.10.4 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.10.5 Silence Therapeutics plc Key News & Latest Developments
7.11 Tacere Therapeutics Inc
7.11.1 Tacere Therapeutics Inc Company Summary
7.11.2 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Business Overview
7.11.3 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.11.4 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.11.5 Tacere Therapeutics Inc Key News & Latest Developments
7.12 PhaseRx Inc
7.12.1 PhaseRx Inc Company Summary
7.12.2 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Business Overview
7.12.3 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.12.4 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.12.5 PhaseRx Inc Key News & Latest Developments
7.13 Sirnaomics Inc
7.13.1 Sirnaomics Inc Company Summary
7.13.2 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Business Overview
7.13.3 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.13.4 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.13.5 Sirnaomics Inc Key News & Latest Developments
7.14 Traversa Therapeutics Inc
7.14.1 Traversa Therapeutics Inc Company Summary
7.14.2 Traversa Therapeutics Inc Business Overview
7.14.3 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.14.4 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2019-2024)
7.14.5 Traversa Therapeutics Inc Key News & Latest Developments
8 Global RNA Interference (RNAi) Drug Delivery Production Capacity, Analysis
8.1 Global RNA Interference (RNAi) Drug Delivery Production Capacity, 2019-2031
8.2 RNA Interference (RNAi) Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA Interference (RNAi) Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RNA Interference (RNAi) Drug Delivery Supply Chain Analysis
10.1 RNA Interference (RNAi) Drug Delivery Industry Value Chain
10.2 RNA Interference (RNAi) Drug Delivery Upstream Market
10.3 RNA Interference (RNAi) Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RNA Interference (RNAi) Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of RNA Interference (RNAi) Drug Delivery in Global Market
Table 2. Top RNA Interference (RNAi) Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 3. Global RNA Interference (RNAi) Drug Delivery Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Companies, 2019-2024
Table 5. Global RNA Interference (RNAi) Drug Delivery Sales by Companies, (K Units), 2019-2024
Table 6. Global RNA Interference (RNAi) Drug Delivery Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers RNA Interference (RNAi) Drug Delivery Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
Table 9. List of Global Tier 1 RNA Interference (RNAi) Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA Interference (RNAi) Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2019-2024
Table 15. By Type - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2024-2031
Table 16. By Application ? Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2019-2024
Table 20. By Application - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2024-2031
Table 21. By Region ? Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2019-2024
Table 25. By Region - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2024-2031
Table 26. By Country - North America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2019-2024
Table 29. By Country - North America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2024-2031
Table 30. By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2019-2024
Table 33. By Country - Europe RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2024-2031
Table 34. By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2019-2024
Table 37. By Region - Asia RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2024-2031
Table 38. By Country - South America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2019-2024
Table 41. By Country - South America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2024-2031
Table 42. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2024-2031
Table 46. Metabolic disorders Company Summary
Table 47. Metabolic disorders RNA Interference (RNAi) Drug Delivery Product Offerings
Table 48. Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Metabolic disorders Key News & Latest Developments
Table 50. Alnylam Pharmaceuticals Inc Company Summary
Table 51. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 52. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Alnylam Pharmaceuticals Inc Key News & Latest Developments
Table 54. Merck & Co. Inc Company Summary
Table 55. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 56. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Merck & Co. Inc Key News & Latest Developments
Table 58. Access Pharmaceuticals Inc Company Summary
Table 59. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 60. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Access Pharmaceuticals Inc Key News & Latest Developments
Table 62. Dicerna Pharmaceuticals Inc Company Summary
Table 63. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 64. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Dicerna Pharmaceuticals Inc Key News & Latest Developments
Table 66. Calondo Pharmaceuticals Inc Company Summary
Table 67. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 68. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Calondo Pharmaceuticals Inc Key News & Latest Developments
Table 70. Marina Biotech Inc Company Summary
Table 71. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 72. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Marina Biotech Inc Key News & Latest Developments
Table 74. RXi Pharmaceuticals Corp Company Summary
Table 75. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product Offerings
Table 76. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. RXi Pharmaceuticals Corp Key News & Latest Developments
Table 78. Quark Pharmaceuticals Inc Company Summary
Table 79. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 80. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Quark Pharmaceuticals Inc Key News & Latest Developments
Table 82. Silence Therapeutics plc Company Summary
Table 83. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 84. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Silence Therapeutics plc Key News & Latest Developments
Table 86. Tacere Therapeutics Inc Company Summary
Table 87. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 88. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. Tacere Therapeutics Inc Key News & Latest Developments
Table 90. PhaseRx Inc Company Summary
Table 91. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 92. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. PhaseRx Inc Key News & Latest Developments
Table 94. Sirnaomics Inc Company Summary
Table 95. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 96. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 97. Sirnaomics Inc Key News & Latest Developments
Table 98. Traversa Therapeutics Inc Company Summary
Table 99. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 100. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 101. Traversa Therapeutics Inc Key News & Latest Developments
Table 102. RNA Interference (RNAi) Drug Delivery Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 103. Global RNA Interference (RNAi) Drug Delivery Capacity Market Share of Key Manufacturers, 2021-2024
Table 104. Global RNA Interference (RNAi) Drug Delivery Production by Region, 2019-2024 (K Units)
Table 105. Global RNA Interference (RNAi) Drug Delivery Production by Region, 2024-2031 (K Units)
Table 106. RNA Interference (RNAi) Drug Delivery Market Opportunities & Trends in Global Market
Table 107. RNA Interference (RNAi) Drug Delivery Market Drivers in Global Market
Table 108. RNA Interference (RNAi) Drug Delivery Market Restraints in Global Market
Table 109. RNA Interference (RNAi) Drug Delivery Raw Materials
Table 110. RNA Interference (RNAi) Drug Delivery Raw Materials Suppliers in Global Market
Table 111. Typical RNA Interference (RNAi) Drug Delivery Downstream
Table 112. RNA Interference (RNAi) Drug Delivery Downstream Clients in Global Market
Table 113. RNA Interference (RNAi) Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. RNA Interference (RNAi) Drug Delivery Segment by Type in 2022
Figure 2. RNA Interference (RNAi) Drug Delivery Segment by Application in 2022
Figure 3. Global RNA Interference (RNAi) Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA Interference (RNAi) Drug Delivery Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global RNA Interference (RNAi) Drug Delivery Revenue, 2019-2031 (US$, Mn)
Figure 7. RNA Interference (RNAi) Drug Delivery Sales in Global Market: 2019-2031 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by RNA Interference (RNAi) Drug Delivery Revenue in 2022
Figure 9. By Type - Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 11. By Type - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 12. By Type - Global RNA Interference (RNAi) Drug Delivery Price (USD/Unit), 2019-2031
Figure 13. By Application - Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 15. By Application - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 16. By Application - Global RNA Interference (RNAi) Drug Delivery Price (USD/Unit), 2019-2031
Figure 17. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 20. By Region - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 21. By Country - North America RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 22. By Country - North America RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 23. US RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 24. Canada RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 27. By Country - Europe RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 28. Germany RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 29. France RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 31. Italy RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 32. Russia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 36. By Region - Asia RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 37. China RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 38. Japan RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 41. India RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 43. By Country - South America RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 44. Brazil RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Market Share, 2019-2031
Figure 48. Turkey RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 49. Israel RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 51. UAE RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2019-2031
Figure 52. Global RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), 2019-2031
Figure 53. The Percentage of Production RNA Interference (RNAi) Drug Delivery by Region, 2022 VS 2031
Figure 54. RNA Interference (RNAi) Drug Delivery Industry Value Chain
Figure 55. Marketing Channels
